Acceleron Pharma Alternatives & Competitors
12 companies similar to Acceleron Pharma — Accelerating drug discovery to transform patients' lives
Companies similar to Acceleron Pharma
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
Westlake Village, United...
Dicerna Pharmaceuticals
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
Charlottesville, United S...
Cambridge, United States
Track all Acceleron Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Edgewise Therapeutics
On a mission to improve the lives of people facing serious muscle disease.
Boulder, United States
Casma Therapeutics
With deep expertise in cellular degradation, Casma is advancing targeted therapies for neu...
Cambridge, United States
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
Illkirch-graffenstaden, F...
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
San Diego, United States
AgeX Therapeutics, Inc.
AgeX Therapeutics is focused on the development and commercialization of novel therapeutic...
Alameda, United States
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Redwood City, United Stat...
Onena Medicines
AI-centric preclinical company discovering and developing novel biopharmaceuticals to trea...
Basel, Switzerland
Ardelyx, Inc.
Translating Scientific Breakthroughs into Promise for Patients
Waltham, United States
About Acceleron Pharma
Acceleron Pharma is a biotechnology company founded in 2003 with a clear vision encapsulated in their slogan, "Accelerating drug discovery to transform patients' lives." On November 22, 2021, the company underwent a significant change as it became a wholly-owned subsidiary of Merck & Co., Inc. This strategic move marks...
Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, Musculoskeletal Diseases, Cancer Therapeutics, Metabolic Disorders, Muscle Loss Therapies, Neuromuscular Diseases, Angiogenesis Therapies, Drug Discovery, Biotherapeutics, Cellular Proliferation, Differentiation Factors, Tissue Regeneration, Clinical Research
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Acceleron Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Acceleron Pharma on 3 Dec 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
